Patent · US Active

Direct protein delivery with engineered microvesicles

US9695446B2 · kind B2 · utility

16Cited by

0References

16Claims

0Family size

Assignee

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR

Inventors

Philippe Mangeot · Lyon, FR
Vincent Lotteau · Val-de-Reuil, FR

Key dates

Filing date	Feb 25, 2014
Grant date	Jul 4, 2017
Priority date	—
Expiry date	Mar 2, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/20222
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to direct protein delivery with engineered micro vesicles.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.